Emerald Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-610
| Closed | -$193K | – | 266 |
|
|
2023
Q4 | $193K | Sell |
610
-26,814
| -98% | -$8.49M | 0.01% | 219 |
|
|
2023
Q3 | $4.64M | Sell |
27,424
-232
| -0.8% | -$39.2K | 0.22% | 111 |
|
|
2023
Q2 | $6M | Sell |
27,656
-49,514
| -64% | -$10.7M | 0.26% | 107 |
|
|
2023
Q1 | $14M | Sell |
77,170
-23,760
| -24% | -$4.32M | 0.67% | 69 |
|
|
2022
Q4 | $19.8M | Sell |
100,930
-18,898
| -16% | -$3.71M | 0.96% | 43 |
|
|
2022
Q3 | $27M | Sell |
119,828
-700
| -0.6% | -$157K | 1.39% | 13 |
|
|
2022
Q2 | $15.2M | Sell |
120,528
-134,028
| -53% | -$17M | 0.78% | 51 |
|
|
2022
Q1 | $32.3M | Buy |
254,556
+23,684
| +10% | +$3M | 1.23% | 24 |
|
|
2021
Q4 | $30.2M | Buy |
230,872
+18,850
| +9% | +$2.47M | 1.12% | 28 |
|
|
2021
Q3 | $25.9M | Buy |
212,022
+7,608
| +4% | +$931K | 0.94% | 41 |
|
|
2021
Q2 | $23.3M | Buy |
204,414
+31,290
| +18% | +$3.57M | 0.85% | 42 |
|
|
2021
Q1 | $20.8M | Buy |
+173,124
| New | +$20.8M | 0.75% | 59 |
|